Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon

Journal of General Virology

Volumn 87, Issue 11, 2006, Pages 3317-3327

  Arita, Minetaro ^a   Nagata, Noriyo ^a   Sata, Tetsutaro ^a   Miyamura, Tatsuo ^a   Shimizu, Hiroyuki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DISEASE SEVERITY; FLACCID PARALYSIS; GENETIC CODE; GRIP STRENGTH; HINDLIMB; HISTOLOGY; HUMAN; HUMAN CELL; INOCULATION; LUMBAR SPINAL CORD; MOTONEURON; MOUSE; NERVE LESION; NONHUMAN; OBSERVATION; PARALYSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; REPLICON; SCORING SYSTEM; SPINAL CORD; TRANSGENIC MOUSE; VIRUS CAPSID; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; CAPSID; CELL LINE; DISEASE MODELS, ANIMAL; HUMANS; LUCIFERASES, FIREFLY; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; PARALYSIS; POLIOMYELITIS; POLIOVIRUS; RECEPTORS, VIRUS; REPLICON; SPINAL CORD; TIME FACTORS; TRANSFECTION; VIRUS REPLICATION;

MIRIDAE; MUS MUSCULUS; POLIOVIRUS;

EID: 33750277766     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82172-0     Document Type: Article

References (57)

1. Abe, S., Ota, Y., Koike, S., Kurata, T., Horle, H., Nomura, T., Hashizume, S. & Nomoto, A. (1995). Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology 206, 1075-1083.
2. Ansardi, D. C., Porter, D. C. & Morrow, C. D. (1993). Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans. J Virol 67, 3684-3690.
3. Arita, M., Koike, S., Aoki, J., Horie, H. & Nomoto, A. (1998). Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J Virol 72, 3578-3586.
4. Arita, M., Horie, H., Arita, M. & Nomoto, A. (1999). Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor. J Virol 73, 1066-1074.
5. Arita, M., Shimizu, H. & Miyamura, T. (2004). Characterization of in vitro and in vivo phenotypes of poliovirus type 1 mutants with reduced viral protein synthes0is activity. J Gen Virol 85, 1933-1944.
6. Arita, M., Shimizu, H., Nagata, N., Ami, Y., Suzaki, Y., Sata, T., Iwasaki, T. & Miyamura, T. (2005). Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 86, 1391-1401.
7. Barclay, W., Li, Q., Hutchinson, G., Moon, D., Richardson, A., Percy, N., Almond, J. W. & Evans, D. J. (1998). Encapsidation studies of poliovirus subgenomic replicons. J Gen Virol 79, 1725-1734.
8. Bjugn, R., Nyengaard, J. R. & Rosland, J. H. (1997). Spinal cord transection - no loss of distal ventral horn neurons. Exp Neurol 148, 179-186.
9. Bledsoe, A. W., Gillespie, G. Y. & Morrow, C. D. (2000). Targeted foreign gene expression in spinal cord neurons using poliovirus replicons. J Neurovirol 6, 95-105.
10. Bodian, D. (1949). Histopathologic basis of clinical findings in poliomyelitis. Am J Med 6, 563-578.
11. Bodian, D. & Howe, H. A. (1941). Neurotropism and the genesis of cerebral lesions in poliomyelitis: an experimental study. Bull Johns Hopkins Hosp 68, 58-76.
12. Brown, D. M., Cornell, C. T., Tran, G. P., Nguyen, J. H. C. & Semler, B. L. (2005). An authentic 3′ noncoding region is necessary for efficient poliovirus replication. J Virol 79, 11962-11973.
13. Campbell, S. A., Lin, J., Dobrikova, E. Y. & Gromeier, M. (2005). Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells. J Virol 79, 6281-6290.
14. Couderc, T., Christodoulou, C., Kopecka, H., Marsden, S., Taffs, L. F., Crainic, R. & Horaud, F. (1989). Molecular pathogenesis of neural lesions induced by poliovirus type 1. J Gen Virol 70, 2907-2918.
15. Couderc, T., Delpeyroux, F., Le Blay, H. & Blondel, B. (1996). Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J Virol 70, 305-312.
16. Couderc, T., Guivel-Benhassine, F., Calaora, V., Gosselin, A.-S. & Blondel, B. (2002). An ex vivo murine model to study poliovirus-induced apoptosis in nerve cells. J Gen Virol 83, 1925-1930.
17. Crotty, S., Hix, L., Sigal, L. J. & Andino, R. (2002). Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection. J Gen Virol 83, 1707-1720.
18. Daley, J. K., Gechman, L. A., Skipworth, J. & Rall, G. F. (2005). Poliovirus replication and spread in primary neuron cultures. Virology 340, 10-20.
19. DeJesus, N., Franco, D., Paul, A., Wimmer, E. & Cello, J. (2005). Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence. J Virol 79, 14235-14243.
20. Destombes, J., Couderc, T., Thiesson, D., Girard, S., Wilt, S. G. & Blondel, B. (1997). Persistent poliovirus infection in mouse motoneurons. J Virol 71, 1621-1628.
21. Dodd, D. A., Niederoest, B., Bloechlinger, S., Dupuis, L., Loeffler, J.-P. & Schwab, M. E. (2005). Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J Biol Chem 280, 12494-12502.
22. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P.-M., Miller, J. H. & Calos, M. P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7, 379-387.
23. Dufresne, A. T. & Gromeier, M. (2004). A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice. Proc Natl Acad Sci U S A 101, 13636-13641.
24. Evans, D. T., Bricker, J. E. & Desrosiers, R. C. (2004). A novel approach for producing lentiviruses that are limited to a single cycle of infection. J Virol 78, 11715-11725.
25. Girard, S., Couderc, T., Destombes, J., Thiesson, D., Delpeyroux, F. & Blondel, B. (1999). Poliovirus induces apoptosis in the mouse central nervous system. J Virol 73, 6066-6072.
26. Gutiérrez, A. L., Denova-Ocampo, M., Racaniello, V. R. & del Angel, R. M. (1997). Attenuating mutations in the poliovirus 5′ untranslated region alter its interaction with polypyrimidine tract-binding protein. J Virol 71, 3826-3833.
27. Hagino-Yamagishi, K. & Nomoto, A. (1989). In vitro construction of poliovirus defective interfering particles. J Virol 63, 5386-5392.
28. Haller, A. A., Stewart, S. R. & Semler, B. L. (1996). Attenuation stem-loop lesions in the 5′ noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J Virol 70, 1467-1474.
29. Ida-Hosonuma, M., Iwasaki, T., Taya, C., Sato, Y., Li, J., Nagata, N., Yonekawa, H. & Koike, S. (2002). Comparison of neuropathogenicity of poliovirus in two transgenic mouse strains expressing human poliovirus receptor with different distribution patterns. J Gen Virol 83, 1095-1105.
30. Jackson, C. A., Cobbs, C., Peduzzi, J. D., Novak M. & Morrow, C. D. (2001). Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the central nervous system without pathogenesis. Hum Gene Ther 12, 1827-1841.
31. Jia, X-Y., Van Eden, M., Busch, M. G., Ehrenfeld, E. & Summers, D. F. (1998). trans-Encapsidation of a poliovirus replicon by different picornavirus capsid proteins. J Virol 72, 7972-7977.
32. Jia, O., Ohka, S., Iwasaki, K., Tohyama, K. & Nomoto, A. (1999). Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice. J Virol 73, 6041-6047.
33. Kaplan, G. & Racaniello, V. R. (1988). Construction and characterization of poliovirus subgenomic replicons. J Virol 62, 1687-1696.
34. Kärber, G. (1931). Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharm 162, 480-483 (in German).
35. Kim, D. W., Uetsuki, T., Kaziro, Y., Yamaguchi, N. & Sugano, S. (1990). Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 91, 217-223.
36. Koike, S., Taya, C., Aoki, J. & 7 other authors (1994). Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene - influence of the transgene expression on pathogenesis. Arch Virol 139, 351-363.
37. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
38. Lemon, S. M. & Honda, M. (1997). Internal ribosome entry sites within the RNA genomes of hepatitis C virus and other flaviviruses. Semin Virol 8, 274-288.
39. McComas, A. J., Quartly, C. & Griggs, R. C. (1997). Early and late losses of motor units after poliomyelitis. Brain 120, 1415-1421.
40. Minor, P. D. (1997). Poliovirus. In Viral Pathogenesis, pp. 555-574. Edited by N. Nathanson, R. Ahmed, F. Gonzalez-Scarano, D. E. Griffin, K. V. Holmes, F. A. Murph & H. L. Robinson. Philadelphia, PA: Lippincott Williams & Wilkins.
41. Nagata, N., Iwasaki, T., Ami, Y. & 7 other authors (2001). Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys. Vaccine 19, 3201-3208.
42. Nagata, N., Shimizu, H., Ami, Y. & 7 other authors (2002). Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol 67, 207-216.
43. Nathanson, N. & Bodian, D. (1961). Experimental poliomyelitis following intramuscular virus injection. I. The effect of neural block on a neurotropic and a pantropic strain. Bull Johns Hopkins Hosp 108, 308-319.
44. Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90, 8392-8396.
45. Porter, D. C., Ansardi, D. C., Wang, J., McPherson, S., Moldoveanu, Z. & Morrow, C. D. (1998). Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase. Virology 243, 1-11.
46. Pyeon, D., Lambert, P. F. & Ahlquist, P. (2005). Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc Natl Acad Sci U S A 102, 9311-9316.
47. Ren, R. & Racaniello, V. R. (1992). Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 66, 296-304.
48. Romanova, L. I., Belov, G. A., Lidsky, P. V. & 7 other authors (2005). Variability in apoptotic response to poliovirus infection. Virology 331, 292-306.
49. Saijo, M., Qing, T., Niikura, M., Maeda, A., Ikegami, T., Sakai, K., Prehaud, C., Kurane, I. & Morikawa, S. (2002). Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol 40, 372-375.
50. Shaw, G., Morse, S., Ararat, M. & Graham, F. L. (2002). Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16, 869-871.
51. Svitkin, Y. V., Maslova, S. V. & Agol, V. I. (1985). The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology 147, 243-252.
52. Svitkin, Y. V., Cammack, N., Minor, P. D. & Almond, J. W. (1990). Translation deficiency of the Sabin rype 3 poliovirus genome: association with an attenuating mutation C472→U. Virology 175, 103-109.
53. Tolskaya, E. A., Romanova, L. I., Kolesnikova, M. S., Ivannikova, T. A. & Agol, V. I. (1996). Final checkpoint in the drug-promoted and poliovirus-promoted apoptosis is under post-translational control by growth factors. J Cell Biochem 63, 422-431.
54. Utagawa, E. T., Nakazawa, E., Matsuo, K., Oishl, I., Takeda, N. & Miyamura, T. (2002). Application of an automated specimen search system installed in a transmission electron microscope for the detection of caliciviruses in clinical specimens. J Virol Methods 100, 49-56.
55. van der Werf, S., Bradley, J., Wimmer, E., Studier, F. W. & Dunn, J. J. (1986). Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A 83, 2330-2334.
56. WHO (1990). Requirements for poliomyelitis vaccine (oral). WHO Tech Rep Ser 800, 30-65.
57. Yanagiya, A., Jia, O., Ohka, S., Horie, H. & Nomoto, A. (2005). Blockade of the poliovirus-induced cytopathic effect in neural cells by monoclonal antibody against poliovirus or the human poliovirus receptor. J Virol 79, 1523-1532.